The rise and fall of raloxifene use for osteoporosis, 1999-2022
Shogry FF, Hayes KN, Kim S, Burden AM, Tadrous M, Aggarwal S, Cadarette SM. Osteoporos Int. 2025 Jun 11 [Epub ahead of prin]t.
Publications
Risk of Guillain-Barré syndrome after COVID-19 vaccination or SARS-CoV-2 infection: a multinational self-controlled case series study
Nasreen S, Jiang Y, Lu H, Lee A, Cutland CL, Gentile A, Giglio N, Macartney K, Deng L, Liu B, Sonneveld N, Bellamy K, Clothier HJ, Sepulveda Kattan G, Naus M, Naveed Z, Janjua NZ, Nguyen L, Hviid A, Poukka E, Perälä J, Leino T, Chandra LA, Thobari JA, Park BJ, Choi NK, Jeong NY, Madhi SA, Villalobos F, Solórzano M, Bissacco CA, Carreras-Martínez JJ, Correcher-Martínez E, Urchueguía-Fornes A, Roy D, Yeomans A, Aurelius T, Morton K, Di Mauro G, Sturkenboom MC, Sejvar JJ, Top KA, Batty K, Ghebreab L, Griffin JB, Petousis-Harris H, Buttery J, Black S, Kwong JC. Vaccine. 2025 May 28;60:127291. [Epub ahead of print].
Association of direct oral anticoagulant-proton pump inhibitor co-therapy with adverse outcomes: a population-based cohort study
Wang M, Paterson JM, Nguyen F, Siegal DM, Targownik L, Holbrook AM. Ann Pharmacother. 2025; May 28 [Epub ahead of print].
Limited durability of protection conferred by XBB.1.5 vaccines against omicron-associated severe outcomes among community-dwelling adults, Ontario, Canada
Lee N, Nguyen L, Nasreen S, Austin PC, Brown KA, Buchan SA, Grewal R, Schwartz KL, Tadrous M, Wilson K, Wilson SE, Kwong JC; Canadian Immunization Research Network (CIRN) Investigators. Vaccine. 2025; May 26 [Epub ahead of print].
Early mortality in patients with cancer and COVID-19 infection treated with immunotherapy
Raphael J, Le B, Singh S, Blanchette P, Trudeau M, Lam M, Cheung M. BMC Cancer. 2025; 25(1):922.
East Asian immigration and direct oral anticoagulant dosing for atrial fibrillation: a population-based cohort study
Nakajima E, Ha ACT, Qiu F, Austin PC, Jackevicius CA, Ko DT, Dorian P, Lee DS, Abdel-Qadir H. Heart Rhythm. 2025: S1547-5271(25)02500-7. Epub 2025 May 22.
Minimum legal age of nonmedical cannabis purchase laws and cannabis-related hospitalizations in Canada, 2015 to 2022
Myran DT, Talarico R, Pacula RL, Xiao J, Manuel D, Hobin E, Konikoff L, Tanuseputro P, Taljaard M. Am J Public Health. 2025; May 22 [Epub ahead of print].
Validation of influenza vaccination status using health administrative databases by integrating pharmacy claims and medical billing databases in Ontario, Canada
Amoud R, Kwong JC, Maxwell C, Tyas SL, Cooke M, Hernandez A, Alsabbagh W. BMC Infect Dis. 2025 May 4;25(1):653.
SGLT2 inhibitors and risk for hyperkalemia among individuals receiving RAAS inhibitors
Wing S, Ray JG, Yau K, Jeyakumar N, Abdullah S, Luo B, Cherney DZI, Harel Z, Hundemer GL, Mavrakanas TA, Molnar AO, Odutayo A, Perl J, Young A, Charytan D, Weir M, Wald R. JAMA Intern Med. 2025; Apr 28 [Epub ahead of print].
Real-world comparative effectiveness and safety of pertuzumab in patients with HER2+ metastatic breast cancer: a pan-Canadian population-based cohort study
Muñoz CE, Dai WF, Cheung WY, de Oliveira C, Pataky RE, Ding PQ, Tran DA, Aurangzeb Z, Nagamuthu C, Liu N, Lethbridge L, McClure C, Vriends K, Xiong H, Folkins C, Somayaji C, Peacock S, Alvi R, Turner D, O’Conaill C, McDonald T, Urquhart R, Kendell C, Dowden J, Strumpf E, Denburg A, Beca JM, Mercer RE, Tadrous M, Takhar P, Chan KKW; CanREValue Collaboration. Int J Cancer. 2025; Apr 23 [Epub ahead of print].